JP2005508936A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508936A5
JP2005508936A5 JP2003533847A JP2003533847A JP2005508936A5 JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5 JP 2003533847 A JP2003533847 A JP 2003533847A JP 2003533847 A JP2003533847 A JP 2003533847A JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5
Authority
JP
Japan
Prior art keywords
composition
skin
salicylate
phytosphingosine
hinokitiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003533847A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508936A (ja
JP3921202B2 (ja
Filing date
Publication date
Priority claimed from US09/971,561 external-priority patent/US6680062B2/en
Application filed filed Critical
Publication of JP2005508936A publication Critical patent/JP2005508936A/ja
Publication of JP2005508936A5 publication Critical patent/JP2005508936A5/ja
Application granted granted Critical
Publication of JP3921202B2 publication Critical patent/JP3921202B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003533847A 2001-10-05 2002-09-18 抗刺激性酒さ治療 Expired - Fee Related JP3921202B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/971,561 US6680062B2 (en) 2001-10-05 2001-10-05 Anti-irritating rosacea treatment
PCT/US2002/029722 WO2003030813A2 (en) 2001-10-05 2002-09-18 Anti-irritating rosacea treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006225842A Division JP2006306899A (ja) 2001-10-05 2006-08-22 抗刺激性酒さ治療

Publications (3)

Publication Number Publication Date
JP2005508936A JP2005508936A (ja) 2005-04-07
JP2005508936A5 true JP2005508936A5 (enExample) 2006-01-05
JP3921202B2 JP3921202B2 (ja) 2007-05-30

Family

ID=25518547

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003533847A Expired - Fee Related JP3921202B2 (ja) 2001-10-05 2002-09-18 抗刺激性酒さ治療
JP2006225842A Pending JP2006306899A (ja) 2001-10-05 2006-08-22 抗刺激性酒さ治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006225842A Pending JP2006306899A (ja) 2001-10-05 2006-08-22 抗刺激性酒さ治療

Country Status (9)

Country Link
US (1) US6680062B2 (enExample)
EP (1) EP1441685B1 (enExample)
JP (2) JP3921202B2 (enExample)
AT (1) ATE414527T1 (enExample)
AU (1) AU2002334601B2 (enExample)
CA (1) CA2461941C (enExample)
DE (1) DE60229971D1 (enExample)
ES (1) ES2316647T3 (enExample)
WO (1) WO2003030813A2 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US7851477B2 (en) * 2003-05-22 2010-12-14 L'oreal Method for the treatment of skin
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20050020600A1 (en) 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
WO2005048929A2 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
KR100778992B1 (ko) * 2004-01-07 2007-11-28 이엘씨 매니지먼트 엘엘씨 체모 성장을 지연시키기 위한 미용 조성물 및 방법
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
AU2005203301A1 (en) * 2004-07-30 2006-02-16 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
DE102005005486A1 (de) * 2005-02-04 2006-08-17 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Herstellung und Verwendung
WO2006134160A2 (en) * 2005-06-17 2006-12-21 Symrise Gmbh & Co. Kg Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US20070191303A1 (en) * 2006-01-19 2007-08-16 Solazyme, Inc. Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions
US20070166266A1 (en) * 2006-01-19 2007-07-19 Solazyme, Inc. Methods and compositions for improving the health and appearance of skin
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
WO2007136428A2 (en) * 2006-01-19 2007-11-29 Solazyme, Inc. Nutraceutical compositions from microalgae and related methods of production and administration
US8277849B2 (en) * 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US7381433B1 (en) * 2007-01-08 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Compositions containing an extract of a primula denticulata and use thereof
WO2009127058A1 (en) * 2008-04-15 2009-10-22 Immanence Integrale Dermo Correction Inc. Skin care compositions and methods of use thereof
EP2116237A1 (en) 2008-08-05 2009-11-11 Polichem SA Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
WO2010054322A1 (en) 2008-11-07 2010-05-14 Solazyme, Inc. Cosmetic compositions comprising microalgal components
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
KR20130018739A (ko) * 2010-03-03 2013-02-25 네오큐티스 에스아 항균 펩티드 격리 화합물을 사용한 피부 질환 및 장애의 치료를 위한 조성물 및 방법
US9180112B2 (en) * 2010-03-23 2015-11-10 Ermis Labs, LLC Dermal compositions containing gorgonian extract
RU2535008C2 (ru) 2010-03-26 2014-12-10 Галдерма Ресерч Энд Девелопмент Улучшенные способы и композиции для безопасного и эффективного лечения телеангиэктазии
MX2012010824A (es) 2010-03-26 2012-10-10 Galderma Res & Dev Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema.
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
SG189896A1 (en) 2010-10-21 2013-06-28 Galderma Sa Brimonidine gel compositions and methods of use
CA2823545C (en) 2010-12-30 2018-11-27 Mary Kay Inc. Cosmetic compositions for treating a dry skin
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
WO2013016072A1 (en) 2011-07-22 2013-01-31 Allergan, Inc. Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases
BR112014009210A2 (pt) 2011-10-19 2017-04-18 Galderma Sa método para a redução da vermelhidão facial cutânea
US9283217B2 (en) 2011-11-10 2016-03-15 Allergan, Inc. Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
UA109359C2 (xx) 2011-11-10 2015-08-10 Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US9949943B2 (en) * 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
BR112015028457A8 (pt) 2013-05-15 2017-10-03 Solazyme Inc Composições cosméticas compreendendo óleo de microalgas
WO2016007601A1 (en) 2014-07-11 2016-01-14 Mary Kay Inc. Pore minimizer
GB2528482A (en) * 2014-07-23 2016-01-27 Skintech Life Science Ltd Pharmaceutical agent
EP3761952B1 (en) * 2018-03-09 2024-08-14 Ocusoft, Inc. Topical skin care compositions
US20250359574A1 (en) 2024-05-22 2025-11-27 Blue Evolution Inc. Composition of and method of extraction of ulva gel from seaweed polysaccharide and protein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599241B2 (en) 1987-06-18 1990-07-12 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and antiviral drugs containing the same as active ingredient
US5306486A (en) 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
FR2732221B1 (fr) 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US5624911A (en) 1995-06-07 1997-04-29 The Regents Of The University Of California Ether derivatives of pseudopterosin
IL114267A0 (en) 1995-06-22 1995-10-31 Univ Ben Gurion Antiviral agents
DE69606514T2 (de) 1995-09-01 2000-09-14 Dsm N.V., Heerlen Derivate von sphingoid basen auf basis von retinoylamid
US5885595A (en) 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
US5811114A (en) 1996-06-12 1998-09-22 E-L Management Corp. Stabilized hinokitiol and compositions containing same
US5728732A (en) 1996-11-27 1998-03-17 Elizabeth Arden Company, Division Of Conopco, Inc. Skin treatment with salicylic acid esters and retinoids
KR100481563B1 (ko) * 1997-09-12 2005-04-08 더 프록터 앤드 갬블 캄파니 피부 또는 모발용 세정 및 컨디셔닝 제품
US20030059447A1 (en) 1997-12-05 2003-03-27 Johannes Wilhelmus J Lambers Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof
US5972993A (en) 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
KR20010071721A (ko) 1998-07-03 2001-07-31 비이체 코이닝 스핑고이드 염기를 생산하는 개선된 미생물 균주
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin

Similar Documents

Publication Publication Date Title
JP2005508936A5 (enExample)
CA2461941A1 (en) Anti-irritating rosacea treatment
ATE401089T1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
EP2961418B1 (en) Acne solution
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
WO2004093569A1 (en) Topical composition on the basis of honey
JP2011522831A (ja) ナノシルバーを含むニキビ治療用組成物及びその使用
CA2600384A1 (en) Compositions and methods for treating acne
CN110035797B (zh) 用于治疗痤疮的具有益生元特性的协同草药组合物
JP2002526407A5 (enExample)
US4735802A (en) Topical dermatological composition and method of treatment
WO2007102090A3 (en) Topical formulation
US20190151394A1 (en) Prebiotic Acne Treatment
JP2005507903A5 (enExample)
US10071052B2 (en) Method for the prevention and treatment of acne
CN105749331A (zh) 一种香紫苏伤口敷料及其制备方法
JP2008543902A5 (enExample)
CN103623152A (zh) 一种祛痘、去痘印、祛除痤疮疤痕的药
EP2588095B1 (en) Composition for the treatment of acne vulgaris
CA2489705A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
JP2009062312A (ja) ニキビ治療剤
PH12022551384A1 (en) Chronic wound healing composition and application thereof
KR101548254B1 (ko) 유황, 명반 및 식초를 유효성분으로 포함하는 피부 질환 치료용 조성물
CN105030639B (zh) 一种拔毒祛痘膏及其制备方法
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤